semaglutide heart failure Design and Baseline Characteristics of STEP-HFpEF Program Evaluating in Patients With Obesity HFpEF Phenotype Oral semaglutide found to lower

Description

Lancet 403 , 379390 (2024)

"Although evidence supporting the use of these medications for alcohol use disorder is growing, the field still needs to learn considerably more about them, particularly in identifying the underlying mechanisms

Offer subcutaneous semaglutide up to 1 mg once weekly for CV, renal and glycaemic benefits (no specific guidance on tirzepatide or oral semaglutide because CVOT results were unavailable at time of review)

Let us help you transform your health through personalized, evidence-based treatment with Zepbound

Monitor your blood glucose regularly, keep a symptom diary, and consider oral rehydration solutions if experiencing gastrointestinal side effects such as nausea or diarrhoea